Vog MV 2mg/500mg/0.2mg Tablet SR
Marketer
Inavars Biologicals Inc
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Vog MV 2mg/500mg/0.2mg Tablet SR
Diabetic patients may find relief with the anti-diabetic medication, MV-Combo 2mg/500mg/0.2mg Extended-Release Tablets. This triple-combination therapy, suitable for adult type 2 diabetes management, effectively regulates blood glucose. Administer this medication with meals, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician based on your blood sugar response. Continuous use is vital; discontinuation without medical consultation may lead to elevated blood sugar, increasing the risk of complications such as kidney impairment, vision loss, neuropathy, and limb amputation. Remember that this medicine is part of a comprehensive approach encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Be prepared to treat hypoglycemia promptly with readily available glucose sources (e.g., sugary snacks, fruit juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia (headache), edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Patients with a history of cardiac disease should inform their physician prior to commencement. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are typically recommended.
Uses of Vog MV 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vog MV 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vog MV 2mg/500mg/0.2mg Extended-Release tablets should be taken on an empty stomach.
Common Side effects of Vog MV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Vog MV 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Vog MV 2mg/500mg/0.2mg Tablet SR should be swallowed whole, without chewing, crushing, or breaking. Administer on an empty stomach.
How Vog MV 2mg/500mg/0.2mg Tablet SR works:
Each Vog MV SR tablet (2mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Vog MV 2mg/500mg/0.2mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vog MV tablets (2mg/500mg/0.2mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vog MV tablets (2mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Vog MV 2mg/500mg/0.2mg SR tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is not advisable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Vog MV 2mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a reduced Vog MV 2mg/500mg/0.2mg Tablet SR dose is typical; however, it's contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Vog MV 2mg/500mg/0.2mg Tablet SR :
Should you forget a dose of Vog MV 2mg/500mg/0.2mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vog MV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently